Erectile dysfunction (ED) affects some 152 million men and their partners worldwide. Fortunately, there is now help for men with erectile dysfunction. Uprima acts as a dopamine receptor agonist that works in the brain to improve erectile function by enhancing the natural process or signal to the penis following sexual stimulation.

Men with impotence who responded to Uprima showed consistently high rates of success over 18 months. Across the entire study period, an average of 92 percent of attempts resulted in an enhanced erection firm enough for intercourse among patients taking Uprima 2 mg. Efficacy was measured as the percentage of attempts resulting in an erection firm enough for intercourse with Uprima, according to patient and partner diary assessments. Both patient and partner evaluations confirmed the success rate.

The findings provide important evidence of the long-term efficacy of Uprima, the first centrally acting oral therapy to be approved for the first- line treatment of erectile dysfunction.